Barclays analyst Lauren Lieberman raised the firm’s price target on Keurig Dr Pepper to $41 from $37 and keeps an Overweight rating on the shares as part of a Q3 earnings preview for the consumer staples group. As the firm reflects on positioning and key debates heading into earnings, it is “struck by how little seems to have changed since the last earnings season over the summer.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper price target raised to $40 from $35 at TD Cowen
- Microsoft downgraded, Pinterest initiated: Wall Street’s top analyst calls
- Keurig Dr Pepper price target raised to $37 from $36 at Deutsche Bank
- Keurig Dr Pepper upgraded to Buy from Neutral at Citi
- Keurig Dr Pepper increases quarterly dividend 7.0% to 23c per share